Other OTC - Delayed Quote USD

Calithera Biosciences, Inc. (CALA)

0.0250 -0.0149 (-37.38%)
At close: April 18 at 2:55 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Stephanie Wong CFO & Secretary 752.42k -- 1974
Dr. Christopher J. Molineaux Ph.D. Senior Vice President of Development 405k -- 1953
Mr. Frank Parlati Ph.D. Senior Vice President of Research -- -- 1969

Calithera Biosciences, Inc.

343 Oyster Point Boulevard
Suite 200
South San Francisco, CA 94080
United States
650 870 1000 https://www.calithera.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
8

Description

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Corporate Governance

Calithera Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jun 05, 2023
    DEFM14A: Proxy Statements
    See Full Filing
  • May 26, 2023
    SC 13D/A: Tender Offer/Acquisition Reports
    See Full Filing
  • Mar 31, 2023
    10-K: Periodic Financial Reports
    See Full Filing
  • Mar 14, 2023
    POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
    See Full Filing
  • Mar 03, 2023
    25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured
    See Full Filing

Upcoming Events

Mar 29, 2024 - Apr 02, 2024
Calithera Biosciences, Inc. Earnings Call

Related Tickers

SCNI Scinai Immunotherapeutics Ltd.
0.4560
+2.70%
 
CWBR CohBar, Inc.
0.9003
0.00%
 
CMMB Chemomab Therapeutics Ltd.
0.7000
+18.64%
 
BCAB BioAtla, Inc.
2.4300
-3.95%
 
SBHMY Sino Biopharmaceutical Limited
7.20
0.00%
 
IBXNF IBEX Technologies Inc.
1.0000
0.00%
 
UCBJF UCB SA
126.05
0.00%
 
CASI CASI Pharmaceuticals, Inc.
2.2400
0.00%
 
UCBJY UCB SA
63.68
-0.61%
 
SBM.V Sirona Biochem Corp.
0.0650
0.00%